Your browser doesn't support javascript.
loading
Treatment approaches to Motor Speech Disorders: A step towards Evidence Based Practice.
Ashraf, Anum; Mumtaz, Nazia; Saqulain, Ghulam.
Afiliação
  • Ashraf A; Anum Ashraf, Senior Lecturer, Faculty of Rehab & Allied Health Sciences, Riphah International University.
  • Mumtaz N; Nazia Mumtaz, PhD Head of Department of Speech Language Pathology, Faculty of Rehab & Allied Health Sciences, Riphah International University.
  • Saqulain G; Dr. Ghulam Saqulain, FCPS (Otorhinolaryngology) HOD & Professor of Otolaryngology, Deputy Dean, Capital Hospital PGMI, Islamabad - Pakistan.
Pak J Med Sci ; 40(3Part-II): 544-548, 2024.
Article em En | MEDLINE | ID: mdl-38356848
ABSTRACT
Motor Speech Disorders is an umbrella term for a set of separate dysfunctions of speech outcome associated with neurological disorders. Motor speech disorders (MSD) are classified as Speech Motor delay (SMD), Childhood dysarthria (CD), Childhood Apraxia of Speech (CAS), and Concurrent CD and CAS. The incidence and prevalence of MSD in population is uncertain. A research gap exists, making evidence-based practice questionable as regards intervention for MSD and is an area of research. Hence, current narrative review was conducted to review and highlight treatment of MSD since evidence-based treatment approach may benefit patient even years after a brain lesion. To achieve this objective literature search was conducted using search engines and data bases including google, google scholar, web of science & PubMed from 1998 to 2023 with keywords "motor speech disorder, dysarthria, apraxia, speech motor delay and combinations of these words with English language and no other limitations. Our search revealed 170 articles, news, publications of which 34 were used for review (Fig.1).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article